Templeton Global Equity Income Fund A(acc)EURRegister to Unlock Ratings |
Performance History | 31/08/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | -2.3 | 9.0 | -1.2 | 7.4 | 12.6 | |
+/-Cat | -4.2 | -9.2 | -0.5 | 0.1 | 3.6 | |
+/-B’mrk | - | -11.3 | -8.0 | 2.6 | 2.8 | |
Category: Global Equity Income | ||||||
Category Benchmark: Morningstar Gbl High Div Yl... |
Key Stats | ||
NAV 27/09/2024 | EUR 21.99 | |
Day Change | 0.13% | |
Morningstar Category™ | Global Equity Income | |
ISIN | LU0211332647 | |
Fund Size (Mil) 31/08/2024 | USD 62.52 | |
Share Class Size (Mil) 27/09/2024 | EUR 2.46 | |
Max Initial Charge | 5.75% | |
Ongoing Charge 31/07/2024 | 1.60% |
Investment Objective: Templeton Global Equity Income Fund A(acc)EUR |
The Fund’s investment objective is to provide a combination of current income and long-term capital appreciation. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Douglas Grant 11/04/2022 | ||
Derek Taner 11/04/2022 | ||
Inception Date 27/05/2005 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI ACWI NR EUR | Morningstar Gbl High Div Yld NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Templeton Global Equity Income Fund A(acc)EUR | 31/08/2024 |
|
|
Top 5 Holdings | Sector | % |
JPMorgan Chase & Co | Financial Services | 5.80 |
UnitedHealth Group Inc | Healthcare | 4.74 |
AstraZeneca PLC | Healthcare | 4.41 |
Hitachi Ltd | Industrials | 4.38 |
Taiwan Semiconductor Manufacturi... | Technology | 4.12 |
Increase Decrease New since last portfolio | ||
Templeton Global Equity Income Fund A(acc)EUR |